Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model

被引:25
|
作者
Naito, Yoshiro [1 ]
Fujii, Aya [1 ]
Sawada, Hisashi [1 ]
Hirotani, Shinichi [1 ]
Iwasaku, Toshihiro [1 ]
Okuhara, Yoshitaka [1 ]
Eguchi, Akiyo [1 ]
Ohyanagi, Mitsumasa [2 ]
Tsujino, Takeshi [3 ]
Masuyama, Tohru [1 ]
机构
[1] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan
[2] Hyogo Coll Med, Dept Internal Med, Div Coronary Heart Dis, Nishinomiya, Hyogo 6638501, Japan
[3] Hyogo Univ Hlth Sci, Dept Pharm, Kobe, Hyogo, Japan
关键词
chronic kidney disease; hypertension; iron; mineralocorticoid receptor; BLOOD-PRESSURE; RAC1; GTPASE; ACCUMULATION; HYPERTENSION; ANGIOTENSIN; INHIBITION;
D O I
10.1097/HJH.0b013e328360381d
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: Iron accumulation is associated with the pathogenesis of chronic kidney disease (CKD). However, little is known about the effects of isolated iron restriction against CKD. We have recently reported that iron restriction prevents the development of renal damage in the well established 5/6 nephrectomy rat model of CKD. Herein, we investigated the therapeutic effects of iron restriction on preexisting hypertension and renal damage in a rat model of CKD. Methods: CKD was induced by 5/6 nephrectomy in Sprague-Dawley rats. After surgery, 5/6 nephrectomized rats were given an iron-restricted diet from 1 day to 16 weeks for prevention protocol or from 8 to 16 weeks for rescue protocol. Other CKD rats were given a normal diet. Results: At 16 weeks after surgery, CKD rats developed hypertension and renal damage. Early intervention with iron restriction prevented the development of hypertension and vascular remodeling. By contrast, late intervention with iron restriction did not remarkably ameliorate preexisting hypertension and vascular remodeling in CKD rats. On the contrary, late intervention with iron restriction prevented further progression of preexisting renal damage in CKD rats. Interestingly, iron restriction led to increased urinary sodium and decreased urinary potassium excretions in CKD rats. Moreover, iron restriction markedly attenuated renal expression of nuclear mineralocorticoid receptor and Rac1 activity in CKD rats. Conclusion: Iron restriction prevented further deterioration of preexisting renal damage. The beneficial effects of iron restriction on renal damage seem to be associated with inhibition of renal mineralocorticoid receptor signaling.
引用
收藏
页码:1203 / 1213
页数:11
相关论文
共 50 条
  • [41] Pseudoxanthoma Elasticum: An Interesting Model to Evaluate Chronic Kidney Disease-Like Vascular Damage without Renal Disease
    D'Marco, Luis
    Lima-Martinez, Marcos
    Karohl, Cristina
    Chacin, Maricarmen
    Bermudez, Valmore
    KIDNEY DISEASES, 2020, 6 (02) : 92 - 97
  • [42] Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease
    Watanabe, Kimio
    Sato, Emiko
    Mishima, Eikan
    Watanabe, Mayu
    Abe, Takaaki
    Takahashi, Nobuyuki
    Nakayama, Masaaki
    HELIYON, 2021, 7 (02)
  • [43] Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation
    Chang, Chia-Chu
    Liou, Hung-Hsiang
    Wu, Chia-Lin
    Chang, Chirn-Bin
    Chang, Yu-Jun
    Chiu, Ping-Fang
    Huang, Ching-Hui
    CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 523 - 529
  • [44] A dual blocker of endothelin A/B receptors mitigates hypertension but not renal dysfunction in a rat model of chronic kidney disease and sleep apnea
    Morales-Loredo, Humberto
    Jones, David
    Barrera, Adelaeda
    Mendiola, Perenkita J.
    Garcia, Joshua
    Pace, Carolyn
    Murphy, Minerva
    Kanagy, Nancy L.
    Bosc, Laura V. Gonzalez
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 316 (05) : F1041 - F1052
  • [45] Heart rate variability as a predictor of rapid renal function deterioration in chronic kidney disease patients
    Chou, Yu-Hsiang
    Huang, Wei-Lieh
    Chang, Chin-Hao
    Yang, Cheryl C. H.
    Kuo, Terry B. J.
    Lin, Shuei-Liong
    Chiang, Wen-Chih
    Chu, Tzong-Shinn
    NEPHROLOGY, 2019, 24 (08) : 806 - 813
  • [46] A Randomized Trial of Distal Diuretics versus Dietary Sodium Restriction for Hypertension in Chronic Kidney Disease
    Bovee, Dominique M.
    Visser, Wesley J.
    Middel, Igor
    De Mik-van Egmond, Anneke
    Greupink, Rick
    Masereeuw, Rosalinde
    Russel, Frans G. M.
    Danser, A. H. Jan
    Zietse, Robert
    Hoorn, Ewout J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (03): : 650 - 662
  • [47] Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease
    Zhang, Shiqin
    Gillihan, Ryan
    He, Nan
    Fields, Timothy
    Liu, Shiguang
    Green, Troy
    Stubbs, Jason R.
    KIDNEY INTERNATIONAL, 2013, 84 (04) : 713 - 721
  • [48] Renal vascular structural properties and their alterations by removal of uraemic toxins in a rat model of chronic kidney disease
    Yamazaki, Hidenori
    Tomoda, Fumihiro
    Koike, Tsutomu
    Kinuno, Hiroyuki
    Sugimori, Hiroko
    Inoue, Hiroshi
    Bannai, Kenji
    Sugano, Mikio
    Nishijima, Fuyuhiko
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2014, 41 (03): : 238 - 245
  • [49] The magnitude of nephron number reduction mediates intrauterine growth-restriction- induced long term chronic renal disease in the rat. A comparative study in two experimental models
    Boubred, Farid
    Daniel, Laurent
    Buffat, Christophe
    Tsimaratos, Michel
    Oliver, Charles
    Lelievre-Pegorier, Martine
    Simeoni, Umberto
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [50] Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model
    Narita, Yuki
    Ueda, Miki
    Uchimura, Kohei
    Kakizoe, Yutaka
    Miyasato, Yoshikazu
    Mizumoto, Teruhiko
    Morinaga, Jun
    Hayata, Manabu
    Nakagawa, Terumasa
    Adachi, Masataka
    Miyoshi, Taku
    Sakai, Yoshiki
    Kadowaki, Daisuke
    Hirata, Sumio
    Mukoyama, Masashi
    Kitamur, Kenichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (02) : 110 - 116